Literature DB >> 18583339

T cell receptor-mediated activation of CD4+CD44hi T cells bypasses Bcl10: an implication of differential NF-kappaB dependence of naïve and memory T cells during T cell receptor-mediated responses.

Hu Zeng1, Yuhong Chen, Mei Yu, Liquan Xue, Xiang Gao, Stephan W Morris, Demin Wang, Renren Wen.   

Abstract

Previous studies have demonstrated that Bcl10 (B-cell leukemia/lymphoma 10) is essential for T cell receptor-mediated NF-kappaB activation and subsequent proliferation and interleukin 2 (IL2) production. However, here we demonstrate that, contrary to expectations, Bcl10 is differentially required for T cell activation, including for both proliferation and cytokine production. When CD4+ and CD8+ T cells were divided based on expression levels of CD44, which distinguishes naïve cells (CD44lo) versus those that are antigen-experienced (CD44hi), IL2 production by and proliferation of CD4+CD44lo naïve cells and both subpopulations of CD8+ T cells were clearly Bcl10-dependent, whereas these same functional properties of CD4+CD44hi T cells occurred largely independent of Bcl10. As with the other subpopulations of T cells, CD4+CD44hi T cells did not activate the NF-kappaB pathway in the absence of Bcl10; nevertheless, these CD4+CD44hi antigen-experienced T cells efficiently secreted IL2 after T cell receptor stimulation. Strikingly, therefore, T cell receptor-mediated IL2 production in these cells is NF-kappaB-independent. Our studies suggest that antigen-experienced CD4+ T cells differ from their naïve counterparts and from CD8+ T cells in their ability to achieve activation independent of the Bcl10/NF-kappaB pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583339      PMCID: PMC2528987          DOI: 10.1074/jbc.M802344200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells.

Authors:  Liquan Xue; Stephan W Morris; Carlos Orihuela; Elaine Tuomanen; Xiaoli Cui; Renren Wen; Demin Wang
Journal:  Nat Immunol       Date:  2003-08-10       Impact factor: 25.606

Review 2.  Protein kinase C(theta) in T cell activation.

Authors:  Noah Isakov; Amnon Altman
Journal:  Annu Rev Immunol       Date:  2002       Impact factor: 28.527

3.  Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.

Authors:  F Köntgen; R J Grumont; A Strasser; D Metcalf; R Li; D Tarlinton; S Gerondakis
Journal:  Genes Dev       Date:  1995-08-15       Impact factor: 11.361

4.  Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation.

Authors:  Marc Schmidt-Supprian; Jane Tian; Ethan P Grant; Manolis Pasparakis; René Maehr; Huib Ovaa; Hidde L Ploegh; Anthony J Coyle; Klaus Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-16       Impact factor: 11.205

5.  Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes.

Authors:  Kim Newton; Vishva M Dixit
Journal:  Curr Biol       Date:  2003-07-15       Impact factor: 10.834

6.  Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation.

Authors:  Takeshi Egawa; Björn Albrecht; Benoît Favier; Mary-Jean Sunshine; Kanchan Mirchandani; William O'Brien; Margot Thome; Dan R Littman
Journal:  Curr Biol       Date:  2003-07-15       Impact factor: 10.834

7.  Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.

Authors:  Astrid A Ruefli-Brasse; Dorothy M French; Vishva M Dixit
Journal:  Science       Date:  2003-10-23       Impact factor: 47.728

Review 8.  The mechanism of action of cyclosporin A and FK506.

Authors:  S L Schreiber; G R Crabtree
Journal:  Immunol Today       Date:  1992-04

Review 9.  NF-kappaB regulation in the immune system.

Authors:  Qiutang Li; Inder M Verma
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

10.  Differential requirement for Malt1 in T and B cell antigen receptor signaling.

Authors:  Jürgen Ruland; Gordon S Duncan; Andrew Wakeham; Tak W Mak
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

View more
  11 in total

Review 1.  Role of T cell-nuclear factor κB in transplantation.

Authors:  Luciana L Molinero; Maria-Luisa Alegre
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

2.  CARMA1 is necessary for optimal T cell responses in a murine model of allergic asthma.

Authors:  Ravisankar A Ramadas; Marly I Roche; James J Moon; Thomas Ludwig; Ramnik J Xavier; Benjamin D Medoff
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

3.  The role of CD44 in fetal and adult hematopoietic stem cell regulation.

Authors:  Huimin Cao; Shen Y Heazlewood; Brenda Williams; Daniela Cardozo; Julie Nigro; Ana Oteiza; Susan K Nilsson
Journal:  Haematologica       Date:  2015-11-06       Impact factor: 9.941

4.  Nuclear export of the NF-κB inhibitor IκBα is required for proper B cell and secondary lymphoid tissue formation.

Authors:  Shelly M Wuerzberger-Davis; Yuhong Chen; David T Yang; Jeffrey D Kearns; Paul W Bates; Candace Lynch; Nicholas C Ladell; Mei Yu; Andrew Podd; Hu Zeng; Tony T Huang; Renren Wen; Alexander Hoffmann; Demin Wang; Shigeki Miyamoto
Journal:  Immunity       Date:  2011-02-17       Impact factor: 31.745

5.  Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.

Authors:  Eran Ophir; Noga Or-Geva; Irina Gurevich; Orna Tal; Yaki Eidelstein; Elias Shezen; Raanan Margalit; Assaf Lask; Guy Shakhar; David Hagin; Esther Bachar-Lustig; Shlomit Reich-Zeliger; Andreas Beilhack; Robert Negrin; Yair Reisner
Journal:  Blood       Date:  2012-12-05       Impact factor: 22.113

6.  Phospholipase C{gamma}1 is essential for T cell development, activation, and tolerance.

Authors:  Guoping Fu; Yuhong Chen; Mei Yu; Andy Podd; James Schuman; Yinghong He; Lie Di; Maryam Yassai; Dipica Haribhai; Paula E North; Jack Gorski; Calvin B Williams; Demin Wang; Renren Wen
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

Review 7.  The role of CARMA1 in T cells.

Authors:  Marly I Roche; Ravisankar A Ramadas; Benjamin D Medoff
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

8.  Ring finger protein 31-mediated atypical ubiquitination stabilizes forkhead box P3 and thereby stimulates regulatory T-cell function.

Authors:  Fuxiang Zhu; Gang Yi; Xu Liu; Fangming Zhu; Anna Zhao; Aiting Wang; Ruihong Zhu; Zuojia Chen; Binbin Zhao; Sijie Fang; Xiao Yu; Ruirong Lin; Rui Liang; Dan Li; Wenyi Zhao; Zizhen Zhang; Wenzhi Guo; Shuijun Zhang; Shengfang Ge; Xianqun Fan; Gang Zhao; Bin Li
Journal:  J Biol Chem       Date:  2018-11-02       Impact factor: 5.157

9.  Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice.

Authors:  Ira Ekmekciu; Eliane von Klitzing; Ulrike Fiebiger; Ulrike Escher; Christian Neumann; Petra Bacher; Alexander Scheffold; Anja A Kühl; Stefan Bereswill; Markus M Heimesaat
Journal:  Front Immunol       Date:  2017-04-19       Impact factor: 7.561

10.  A multi-omic analysis of human naïve CD4+ T cells.

Authors:  Christopher J Mitchell; Derese Getnet; Min-Sik Kim; Srikanth S Manda; Praveen Kumar; Tai-Chung Huang; Sneha M Pinto; Raja Sekhar Nirujogi; Mio Iwasaki; Patrick G Shaw; Xinyan Wu; Jun Zhong; Raghothama Chaerkady; Arivusudar Marimuthu; Babylakshmi Muthusamy; Nandini A Sahasrabuddhe; Rajesh Raju; Caitlyn Bowman; Ludmila Danilova; Jevon Cutler; Dhanashree S Kelkar; Charles G Drake; T S Keshava Prasad; Luigi Marchionni; Peter N Murakami; Alan F Scott; Leming Shi; Jean Thierry-Mieg; Danielle Thierry-Mieg; Rafael Irizarry; Leslie Cope; Yasushi Ishihama; Charles Wang; Harsha Gowda; Akhilesh Pandey
Journal:  BMC Syst Biol       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.